← Back

Jiangsu Hualan New Pharmaceutical Material Co. Ltd.

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. researches, develops, manufactures, and sells packaging materials for injectable pharmaceuticals in China and internationally. Its products include laminated and conventional rubber stoppers, halogenated butyl rubber stoppers with polytetrafluoroethylene or polyester film, and rubber components for pen syringes (cassette vials), assemblies for plastic infusion containers, silicone rubber products, and medical devices and accessories. The company was founded in 1992 and is based in Jiangyin, China.

Country
Price · split & dividend adjusted
News & notes moving 301093.CS
301093.CS▼

Hualan Co., Ltd. reports first-half 2026 net profit of 7.6726 million yuan, down 82.46% year-on-year

Hualan Co., Ltd. released its 2026 interim report, showing total operating revenue of 298 million yuan, down 3.47% from the same period last year. Net profit attributable to the parent company was 7.6726 million yuan, down 82.46% year-on-year. Net cash inflow from operating activities was 22.352 million yuan, down 53.97% year-on-year. The company's latest asset-liability ratio was 15.30%, gross margin was 39.02%, return on equity was 0.35%, and diluted earnings per share was 0.04 yuan. The number of shareholders was 11,800, and the top ten shareholders held 53.84% of the total share capital.
301093.CS ▼
Jiemian·23dRead more →
301093.CS▲

Swiss West Economic Development Agency Visits Hualan Shares to Discuss Global Pharmaceutical Packaging Layout and AI Pharma Strategy

A delegation led by Thomas Bohn, CEO of the Swiss West Economic Development Agency, visited Hualan Shares. The two sides held in-depth discussions on Hualan Shares' investment in the Natural Constant project, the global layout of pharmaceutical packaging materials, and the strategic development of AI in pharmaceuticals. The Swiss West Economic Development Agency expressed that it will provide comprehensive official service support for Hualan Shares' investment implementation in Switzerland, and assist in connecting with Swiss and European industrial resources. Hualan Shares' management accompanied the guests on a tour of the intelligent production factory, where its smart manufacturing level and quality control system were highly recognized. This exchange marks the formal establishment of a regular communication channel between the two sides, kicking off a new chapter of two-way empowerment cooperation between the Chinese and Swiss pharmaceutical industries.
301093.CS ▲
证券时报·58dRead more →
301093.CS▼

Hualan Co. Controlling Shareholder Hualan Electromechanical Pledges 3.9 Million Shares

Hualan Co.'s controlling shareholder, Jiangyin Hualan Electromechanical Technology Co., Ltd., has pledged 3.9 million shares, representing 8.07% of its holdings and 1.83% of the company's total share capital. As of the announcement date, Jiangyin Hualan Electromechanical has cumulatively pledged 6.11 million shares, accounting for 12.65% of its holdings and 2.87% of the company's total share capital. In the first quarter of 2026, Hualan Co. achieved revenue of 130 million yuan and a net profit attributable to the parent company of 610,000 yuan.
301093.CS ▼
财中社·65dRead more →
© 2026 MarketDXAsset